Search Results
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial
ASCO 2015: Nivolumab Shows Highly Promising Activity in Advanced Liver Cancer in Early-Stage Trial
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial
Promising results for nivolumab in advanced liver cancer
Second-Line Nivolumab in Liver Cancer
Considerations for Using Nivolumab in Advanced HCC
Anthony El-Khoueiry, MD, talks results of nivolumab (Opdivo) trial in Hepatocellular Carcinoma (HCC)
Dr. Welling on the Efficacy of Nivolumab in HCC
Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma
Priority Review Designations in RCC and NSCLC, Promising Results in HCC Trial, and More
HCC: Optimizing Outcomes With New and Emerging Treatment Approaches
Frontline Clinical Trials in Liver Cancer